Antoine P. de Kettenis de Hollaeken

Sambrinvest SA is a venture capital firm founded in 1985. Sambrinvest SA is headquartered in Gosselies, Belgium.

Fernand Georges SA sells and distributes industrial tools and hardware equipment. It offers hooks, screws, hinges, plugs, anchors, wood adhesives, sealants, table legs and handles. The firm also provides logistics services to the customers residing in Belgium. The company was founded in 1980 and is headquartered in Charleroi, Belgium.

Well Pumps SA designs and manufactures submersible pumps. Its products include 3''WPS, 3''WPS-CP, 4''WPS, 4''WPS-CP, 6''WPS and 8''WPS. The firm's products are amplified with new proprietary pumps WPS N and WPS NE made of 316 stainless steel and special intermediate bearings (Viton). The company was founded in 1993 and is headquartered in Fleurus, Belgium.

Chauraci SA wholesales and distributes heating and plumbing equipment and supplies. It offers heating, renewable energies, air conditioning, plumbing and water treatment equipment. The firm offers brands that include Saint Roch, Jaga, Grohe, Detremmerie and Ideal-Standard. The company was founded in 1966 and is headquartered in Lodelinsart, Belgium.

Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium.

Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020.

DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium.

Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France.

Part of Mainsys Engineering, Mainsys Financial Software SA operates financial software applications. The company is based in Ottignies-Louvain-la-Neuve, Belgium. The CEOs are Gauthier Storm, Alexandre Degrijse. The Belgian company was founded in 2018.

Mainsys Group NV is an IT services and software editing Belgian company that specializes in providing innovative products and services to support banks in their digital and compliance challenges. The private company is based in Brussels, Belgium and was founded in 1995. The company's solutions for retail and private banks include Fronteo web and mobile banking, F2B core banking, Fronteo loans, and Cocpit - information flow. The company also offers Fronteo sign, a frictionless two-factor authentication experience, and Fronteo open banking, a complete solution for the implementation of the new PSD2 directive. The CEOs are Pierre Lemaire, Jean-Valéry Duvieusart.